We previously demonstrated that a member of the Hedgehog gene family, Indian hedgehog (Ihh), is expressed in the visceral endoderm of EC and ES cell embryoid bodies and mouse embryos. Overexpression studies suggested that Ihh was involved in visceral endoderm differentiation. We now provide evidence for a Hh response in the embryoid body core and in the mesothelial layer of the visceral yolk sac. We also demonstrate that treatment of ES embryoid bodies with the Hh antagonists cAMP and forskolin results in downregulation of the Hh response and altered embryoid body differentiation. The outer endoderm layer undergoes a transition to parietal endoderm while formation of an embryonic ectoderm layer surrounding a cavity is inhibited. These treatments also result in a decrease in the expression of markers for the mesoderm derivatives, blood and endothelial cells. We present a model to explain how Ihh and BMP signaling may regulate extraembryonic endoderm and embryonic ectoderm differentiation. q
Introduction
Extraembryonic cell types, including extraembryonic endoderm, in¯uence early patterning and lineage decisions in vertebrate embryos, yet relatively little is known about how these cell types arise during early development. In the mouse embryo, visceral endoderm derives from the primitive endoderm cells, which arise on the surface of the inner cell mass facing the blastocoel cavity (Rossant and Papaionnou, 1977; Gardner, 1983) . The residual inner cell mass cells form the embryonic ectoderm, or epiblast, which goes on to form the embryo proper while the primitive endoderm cells generate two types of extraembryonic endoderm, parietal and visceral. The parietal endoderm cells migrate along the inner trophectoderm surface and contribute to the parietal yolk sac, while the visceral endoderm cells form a columnar epithelial layer adjacent to the epiblast and contribute to the visceral yolk sac (Rossant and Papaionnou, 1977; Gardner, 1983 ).
An increasing body of evidence indicates that the visceral endoderm provides instructional cues for anterior/posterior patterning of the epiblast just prior to gastrulation. A specialized region of the anterior visceral endoderm known as the AVE, which forms at this time, has been described as the anterior organizer (Beddington and Robertson, 1999) . A number of genes, including Hex (Thomas et al., 1998) , Cer (Belo et al., 1997) , and Otx2 (Acampora et al., 1998) , as well as the antigen VE1 (Rosenquist and Martin, 1995) , are selectively expressed in this region and appear to be essential for establishing anterior/posterior patterning. More recently, the visceral endoderm has been shown to play an instructive role in differentiation of posterior derivatives of the epiblast ( Belaoussoff et al., 1998) . Early in gastrulation, extraembryonic mesoderm, formed from the epiblast, migrates proximally and comes to lie beneath the visceral endoderm in the area of the exocoelomic cavity. These mesoderm cells differentiate into a mesothelial layer adjacent to the exocoelomic cavity and into the blood and endothelial cells that form the blood islands of the visceral yolk sac (Jolie, 1990; Palis et al., 1995) . Tissue recombination experiments indicate that the visceral endoderm is the source of a diffusible signal essential for differentiation of the underlying extraembryonic mesoderm into the hematopoietic lineage (Belaoussoff et al., 1998) . The instructive nature of this signal is emphasized by the observation that visceral endoderm can induce anterior epiblast tissue, destined to make neural ectoderm, to differentiate into hematopoietic cells ( Belaoussoff et al., 1998 ). An important signaling role for the visceral endoderm is also suggested by chimera analysis which demonstrates that the early embryonic lethal phenotype manifested by a number of targeted gene mutations, including nodal (Varlet et al., 1997) , Otx2 (Rhinn et al., 1998) , HNF-4 (Duncan et al., 1997) , and HNF3b (Filosa et al., 1997) , is due to the absence of wild type gene function in the extraembryonic tissues, primarily the visceral endoderm.
We have recently established that a member of the Hedgehog (Hh) gene family, Indian hedgehog (Ihh), is expressed in the visceral endoderm (Becker et al., 1997) .
Hh genes encode a family of secreted signaling molecules that play key roles in pattern formation and differentiation in a variety of species. In the mouse, three Hh genes have been identi®ed Tabin and McMahon, 1997) . Sonic hedgehog (Shh), the most extensively studied of these genes, plays a key role in a variety of developmental events, including dorsal/ventral patterning of the neural tube and somites and anterior/posterior patterning of the limb. Desert hedgehog is essential for spermatogenesis . A number of studies point to a critical role for Ihh in chondrogenesis Vortkamp et al., 1996) , and the recently reported phenotype of Ihh-de®cient mice supports this conclusion (St-Jacques et al., 1999) . However, in addition to the defects in skeletal morphogenesis, 50% of the Ihh-null embryos die between days 10.5 and 12.5 due to circulatory abnormalities likely resulting from the absence of Ihh in the visceral endoderm of the yolk sac (St-Jacques et al., 1999) . The functional role played by Ihh in yolk sac differentiation remains unclear.
Hedgehog (Hh) proteins undergo an unusual autoproteolytic processing event producing an active amino peptide which is covalently modi®ed by cholesterol and/or palmitic acid (Porter et al., 1995 (Porter et al., , 1996a Pepinsky et al., 1998) . The lipid modi®cation is not essential for peptide function but likely mediates membrane association and concentrates the peptide close to its site of synthesis, creating a steep concentration gradient (Chen and Struhl, 1996; Beachy et al., 1997) . The amino peptide binds to a heterodimeric receptor complex encoded by the patched (ptc) and smoothened (smo) genes (Marigo et al., 1996; Stone et al., 1996) . In the absence of Hh peptide, the 12-membrane pass protein Ptc suppresses the signaling activity of Smo, a sevenmembrane pass protein that resembles a G-protein linkedreceptor (Alcedo et al., 1996) . Upon Hh binding, Ptcmediated suppression of Smo is relieved, allowing downstream signaling.
The response to Hh signals includes certain conserved components, such as the upregulation of expression of the ptc1 gene (Goodrich et al., 1996) and members of the cubitus interuptus/gli gene family (Alexandre et al., 1996) , which encode zinc ®nger-containing transcription factors. Increased Ptc expression is thought to play a role in further sequestering the Hh peptide, whereas Gli proteins mediate the expression of downstream effectors of Hh signaling. There are three gli genes in the mouse that appear to be functionally redundant (Hui et al., 1994; Mo et al., 1997) . Recent studies suggest a mechanism whereby Hh signaling promotes expression of the downstream effector gene gli1 and explain how protein kinase A (PKA) can inhibit Hh (Li et al., 1995; Hammerschmidt et al., 1996; Altaba, 1999; Aza-Blanc and Kornberg, 1999) . The polypeptides encoded by the gli2 and gli3 genes can be proteolytically processed, producing an N-terminal transcriptional repressor, whereas the full length protein acts as an activator. The processing event is promoted by PKA-mediated phosphorylation at multiple sites in the Gli1 and Gli3 polypeptides (Dai et al., 1999; Sasaki et al., 1999) . Hh signaling inhibits processing and thereby promotes the expression of gli1. The Gli1 protein itself lacks the repressor domain and appears to act exclusively as a positive transcriptional mediator of Hh action (Dai et al., 1999) .
Previously we have shown that Ihh is expressed by the visceral endoderm in embryonal carcinoma (EC) and embryonic stem (ES) cell-derived embryoid bodies as well as in day 7.5 and 9.5 embryos (Becker et al., 1997) . Expression of Ihh in the visceral endoderm layer of the visceral yolk sac at day 10.5 has also been noted by Farrington et al. (1997) . F9 teratocarcinoma cell lines overexpressing Ihh express visceral endoderm markers in the absence of the inducer retinoic acid (Becker et al., 1997) . This observation raises the possibility that Hh signaling may act in an autocrine fashion to stimulate endoderm differentiation, with the same cells producing and responding to Hh. In most instances where Hh signaling has been examined, however, Hh-secreting cells signal adjacent non-expressing cells, which respond by upregulating downstream genes.
The current study was undertaken to examine further the role of Ihh signaling in visceral endoderm differentiation and to determine if Ihh elicits a response in the embryoid body core. We now provide evidence for a model that describes how Ihh signaling promotes both visceral endoderm differentiation and the maturation of the embryoid body core into embryonic ectoderm. This evidence includes demonstrating that the embryoid body core responds to the Hh signal by upregulating ptc1 and gli gene expression. We also show that treatment with cAMP or forskolin, which promote PKA activity (Francis and Corbin, 1994; Robbins et al., 1996) and antagonize Hh signaling (Pan and Rubin, 1995) , results in reduced levels of ptc1 and gli gene expression. In support of a role for Ihh in visceral endoderm differentiation, when the Hh signal is inhibited by these treatments, there is a conversion of endoderm type from visceral to parietal endoderm. These treatments also alter the differentiation of embryoid body cores as well, inhibiting the formation of a columnar layer of embryonic ectoderm surrounding a cavity. We also provide data that suggest a role for Hh signaling in blood island differentiation. ptc1 is expressed in the extraembryonic mesodermderived mesothelial cell layer in day 8 embryonic visceral yolk sacs, adjacent to the cells that give rise to both blood and endothelial cells. In addition, cAMP or forskolin treatment inhibits the formation of blood islands and the accumulation of certain blood and endothelial cell markers. We also relate our conclusions to the recently reported phenotype of Ihh-de®cient mice.
Results

Ihh and ptc expression in embryoid bodies and embryos
In order to determine if the inner core of differentiating D3 ES embryoid bodies responds to the Ihh signal secreted by the outer viseral endoderm layer, we examined the spatial pattern of expression of ptc1, in comparison to Ihh, by in situ hybridization (Fig. 1A) . At day 4, the expression of Ihh is just beginning to appear in the outer layer of differentiating endoderm cells. ptc1 levels are quite low at this stage. By day 9, however, when Ihh is expressed at high levels selectively in the outer layer of visceral endoderm, ptc1 expression is selectively upregulated in the inner core cells, now in the process of forming an epithelial layer that corresponds to embryonic ectoderm or epiblast tissue. ptc1 expression is not uniform throughout the core but often appears to de®ne the single layer of core cells below the visceral endoderm, which are forming the embryonic ectoderm (Fig. 1A) . The expression of Ihh in the outer layer and Immunocytochemistry was performed on day 7 embryoid bodies which had been embedded in paraf®n and sectioned. Antibodies against Ihh and ptc1 reveal that IHH protein is found in the outer layer of endoderm cells, and that PTC1 protein is found in the underlying layer of ectoderm cells. (C,D) In situ hybridization of ptc1 and Ihh in day 14 ES D3 embryoid bodies, and day 8 mouse embryos. Embryos and embryoid bodies were probed in whole mount for Ihh and ptc1 mRNA expression, and then embedded in paraf®n and sectioned. Ihh is expressed in the visceral endoderm cell layer in both embryoid bodies and the embryo (C). (See insets for detail.) Note also the blood islands visible in the embryoid body (arrow in inset). ptc1 is expressed in a layer of cells just beneath the visceral endoderm in the embryoid body (D). In the embryo, ptc1 is expressed at high levels in the ventral neuroepithelial layer destined to become the¯oor plate of the neural tube, and also in a thin layer of cells within the extraembryonic mesoderm layer, beneath the visceral endoderm (D). (See insets for detail.) ptc1 in the core is still evident at day 11 and through day 16 (data not shown). Using a monoclonal antibody directed against the amino-terminal Shh peptide (which cross-reacts with Ihh), and a monoclonal antibody directed against the Ptc1 protein, we also show that the proteins appear to demonstrate the same spatial distribution pattern observed for the mRNA at day 7 (Fig. 1B) .
Given our previous observation that Ihh is expressed in the outer visceral endoderm layer of the yolk sac in the day 8±9 embryo (Becker et al., 1997) , we wished to determine if ptc1 is also expressed in the layer adjacent to the visceral endoderm in the visceral yolk sac of the embryo. We now show that ptc1 is expressed beneath the Ihh-expressing visceral endoderm in the underlying extraembryonic mesoderm layer of day 8 embryos (Fig. 1C,D) . In the embryos shown, the visceral yolk sac has not yet formed blood islands and therefore the underlying mesoderm has not yet fully differentiated into blood cells or vasculature. Based on their position in the outer layer of mesoderm facing the exocoelomic cavity, the ptc-expressing cells appear to be mesothelial cells. These cells are adjacent to the hemangioblast precursors of the blood and vascular cells of the blood island (Choi et al., 1998) . Note that in the embryo proper, ptc is expressed at high levels in the ventral neuroepithelium, destined to form the¯oor plate of the forming neural tube (see arrow in Fig. 1D ), a site previously demonstrated to upregulate ptc expression in response to Shh signaling (Goodrich et al., 1996) . Day 14 embryoid bodies are included for comparison. Note that embryoid bodies at this stage have undergone expansion into structures that may form blood islands (note blood island (bi) in day 14 embryoid body shown in Fig. 1C ). The layer underneath the visceral endoderm in this case is only one cell diameter thick, but clearly is expressing ptc. Taken together, the embryoid body and embryo data are consistent with a Hh response in cells adjacent to the Ihh-secreting visceral endoderm.
The gli genes gli1, gli2, and gli3 are key components of the Hh response. Fig. 2 demonstrates that expression of all three of these genes is localized in the embryonic ectoderm layer below the visceral endoderm of embryoid bodies at days 8 and 14.
To more fully characterize the nature and extent of the Ihh response, we wished to determine the temporal pattern of expression of members of the Hh cascade relative to Ihh accumulation. We therefore turned to RT-PCR analysis (Fig. 3A) . The data for two independent experiments are shown. As we have previously demonstrated, levels of Ihh mRNA are below the level of detection in D3 stem cells and increase throughout the culture period through day 14 Fig. 2 . In situ hybridization of ptc1, gli1, gli2, and gli3 in ES D3 embryoid bodies. Day 4, 8, and 16 embryoid bodies were probed in whole mount for ptc1, gli1, gli2, and gli3 mRNA expression, and then embedded in paraf®n and sectioned. Note that all four genes are upregulated in the embryonic ectoderm cells at days 8 and 16. (Becker et al., 1997) . The ptc1 gene is expressed in the ES stem cells and modestly upregulated during the time course, beginning at day 4. The expression in stem cells is not unexpected, given the observation that numerous cell lines express low levels of the ptc1 gene (Marigo et al., 1996) . The smo gene is also expressed at low levels in stem cells and upregulated somewhat during differentiation. Levels of gli2 and gli3 appear relatively constant throughout the culture period, with a possible modest upregulation observed for gli1. Shh is not expressed in these cultures until between days 11 and 14, which is too late to be responsible for the ptc1 and gli expression observed in the embryoid body cores (data not shown). At these stages in situ hybridization analysis suggests that Shh is expressed in a subset of interior cells in D3 embryoid bodies (data not shown). Dhh expression could not be detected in these embryoid bodies (data not shown).
Since Bmp2 and Bmp4 are often expressed at sites of Hh action, we investigated their temporal pattern of expression. Fig. 3A shows that Bmp4 mRNA is absent in stem cells in one experiment and present in the other, and modestly upregulated during differentiation, while Bmp2 mRNA is dramatically upregulated in a time course resembling Ihh expression. These data on the accumulation of Bmp4 and Bmp2 support our previously published Northern analysis for a different ES cell line (Grabel et al., 1998) , although they differ from the in situ data reported for PSA EC embryoid bodies. Those data showed a decline in Bmp4 expression as the embryoid bodies matured (Coucouvanis and Martin, 1999) , when we still see a high level of expression.
Given our goal of de®ning those differentiation events which rely upon Ihh signaling, we needed to establish the temporal pattern of expression of a variety of markers of embryoid body differentiation in order to identify likely targets of Hh action. We therefore carried out RT-PCR analysis for a number of genes expressed during visceral endoderm and mesoderm formation (Fig. 4B ). mRNA levels of the visceral endoderm markers AFP and HNF-4 are dramatically upregulated during these time courses. Vascular endothelial growth factor (VEGF) (Brier et al., 1992 ) is present in undifferentiated stem cells, and levels remain constant throughout differentiation. In contrast, several of the genes encoding tyrosine kinase receptors for the VEGFs and angiopoietins, Flt1, Flt4, Flk1, Tie1, and Tie2 (Yamaguchi et al., 1993; Hanahan, 1997) , appear to be upregulated during ES cell differentiation.¯t1 appears to be upregulated by day 4 or 5, whereas¯k1, tie1 and tie2 are upregulated by day 8 or 10.¯t4 is expressed in stem cells in one experiment, downregulated at day 5 and upregulated at day 10, whereas in the other experiment low levels of message are expressed Fig. 3 . RT-PCR analysis of hedgehog cascade and embryoid body differentiation markers. Total RNA from ES D3 stem cells, and day 4, 8, 11, and 14 embryoid bodies was used as template for RT-PCR. The RT-PCR was repeated with RNA from day 5, 7, and 10 embryoid bodies from a different time course. HPRT primers were used to show that equal amounts of cDNA were loaded into each PCR reaction. (A) Genes known to act downstream of the Hh signal. Note that Ihh and Bmp2 are signi®cantly upregulated as the embryoid bodies mature, and that the other genes are modestly upregulated. (B) Expression of several genes known to be expressed during visceral endoderm and mesoderm differentiation. Note in particular that AFP, the visceral endoderm marker, is upregulated as embryoid bodies mature, as are the vasculogenesis/hematopoietic markers Flk, Tie-1, Tie-2, and Bh-1.
in stem cells, elevated levels at days 4, 8, and 11, and decreased levels at day 14. The embryonic globin gene Bh-1 (Leder et al., 1992) shows elevated levels of expression by day 10 or 11. ES cell cultures have been frequently used to study both hematopoiesis and vasculogenesis (Keller, 1995; Weiss, 1997) . Our observations of the temporal pattern of expression of these markers in ES cell cultures are consistent with the previously reported studies, with the exception that¯k1 is generally seen as an early marker with the message levels increasing prior to day 8. The observation that the expression of a number of these genes increases coincident with or subsequent to the upregulation in Ihh expression raises the possibility that Ihh may modulate their accumulation.
The effect of the Hh antagonists cAMP and forskolin on embryoid body differentiation
The expression data described above are consistent with a role for Hh signaling in differentiation of the embryonic ectoderm. To test this model, we used inhibitors of Hh signaling. To determine if treatment with the inhibitors resulted in the predicted decrease in Hh signaling, we turned to a rapid, sensitive assay for Hh response using a ptc1 heterozygous cell line generated by gene targeting with the K01 targeting vector in R1 ES cells. These cells were used to generate ptc1-de®cient mice (Goodrich et al., 1997) . In the targeted heterozygous ES cell line, the lacZ gene is placed downstream of the ptc gene 5 H regulatory elements. In heterozygous embryos generated from this cell line, ptclacZ, as assayed by b-galactosidase staining, is expressed in regions previously demonstrated to express ptc1 (Goodrich et al., 1997) . We now show that embryoid bodies derived from the heterozygous cell line express ptc-lacZ in the interior core of differentiating embryoid bodies at day 8/9 in a spatial pattern equivalent to that observed for ptc1 mRNA (Fig. 4) .
A number of studies in Drosophila and vertebrates indicate that Hh signaling can be antagonized downstream of signal reception by stimulating PKA activity (Li et al., 1995; Hammerschmidt et al., 1996) . We therefore treated the ptc1 2/1 cell line with dibutyryl cyclic AMP (cAMP) and forskolin, two agents known to elevate the activity of PKA. An initial time course established minimum effective concentrations for each compound (0.5 mM cAMP and 2.5 mM forskolin). Fig. 5A shows that by day 10 there was a marked decrease in the level of ptc-lacZ expression using both agents, suggesting effective inhibition of Hh signaling. There was also a consistent decrease in the level of gli1 and gli3 expression as assayed by RT-PCR analysis at both day 7 and 10 ( Fig. 5B) . Levels of gli2 mRNA appeared unchanged in one experiment and downregulated by the treatments in the other experiment. Fig. 5B shows that these agents do not signi®cantly affect the levels of Ihh mRNA produced. This observation is consistent with PKA action blocking Hh signaling downstream of the signal itself. The morphology of treated embryoid bodies indicates that cavity formation and elaboration of a columnar embryonic ectoderm layer were inhibited by both cAMP and forskolin treatment (Fig. 5A,C) . Consistent with our previous observations implicating a role for Ihh in visceral endoderm differentiation, we also observed a phenotypic transition of the treated embryoid body outer endoderm layer from a visceral morphology (tight, single layer of columnar epithelial cells, see inset Fig. 5A control) to an appearance more characteristic of parietal endoderm (irregular outer layer of rounded, more loosely associated cells, see inset Fig. 5A cAMP) (Fig. 5A,C) . This interpretation was substantiated by performing both in situ hybridization and Northern hybridization analysis for the expression of a visceral endoderm marker, AFP (Fig. 5A,D) , and Northern analysis for a parietal endoderm marker, tissue-type plasminogen activator (tPA) (Fig. 5D) . In Fig. 5A , untreated embryoid bodies appear to express high levels of AFP, Fig. 4 . In situ hybridization and lacZ staining of R1 1/2 ptc/lacZ ES embryoid bodies. Day 8 embryoid bodies were ®xed and stained with X-gal as an indicator of ptc1 mRNA expression. In situ hybridization for expression of Ihh and ptc1 was performed on day 9 embryoid bodies as in Fig. 1. (A,B) The expected pattern of Ihh and ptc1 expression (see Fig. 1 ). (C) The spatial pattern of X-gal staining is the same as the spatial pattern of ptc1 expression.
whereas embryoid bodies treated with either cAMP or forskolin express low levels of AFP, consistent with a visceral to parietal endoderm transition. Northern analysis shown in Fig. 5D provides support for this transition and demonstrates that levels of AFP are lower in treated cells at days 7 and 10 while they are producing signi®cantly higher levels of tPA than the untreated controls. This experiment has been repeated several times with essentially identical results.
These data suggest that cAMP or forskolin treatment, which increases PKA activity, results in a downregulation of Ihh signaling, a transition in the outer endoderm layer from visceral to parietal, as well as an inhibition of embryonic ectoderm differentiation and cavity formation.
To determine if treatment with cAMP or forskolin could induce either the endoderm transition or the decrease in ptc expression if added after embryoid body differentiation was already initiated, we grew the ptc1 2/1 cell line as embryoid bodies for 7 days and then began treatment. The nature and extent of differentiation was then evaluated at day 13. Fig.  6A shows that a pulse of forskolin is more effective than cAMP at decreasing the hedgehog response, as measured by lacZ expression. This observation is quanti®ed in Fig. 6B . Fig. 6A ,B also suggests that the transition from visceral to parietal endoderm is stronger with forskolin than with cAMP treatment. This observation is substantiated by the Northern hybridization data shown in Fig. 6C . In control embryoid bodies, levels of both AFP and tPA message increase between days 7 and 13, as expected, and cAMP does not appear to alter the levels of these two markers. In contrast, forskolin treatment promotes tPA mRNA expression above the levels seen in control embryoid bodies, and inhibits the accumulation of AFP mRNA. Levels of Ihh are not altered by either treatment. Despite the endoderm transition and decrease in ptc expression observed in the presence of forskolin, morphological observation of the embryoid bodies (Fig. 6A,B) suggests a far less signi®cant change in the embryoid body core than observed when embryoid bodies differentiate in the constant presence of the compounds. This may be because signals from the visceral endoderm, including Ihh, have already altered the fate of the core by day 7. Fig. 6B also suggests that cAMP, administered as a pulse, exerts an effect on endoderm differentiation without affecting the morphology of the embryoid body core. Again, this is most likely because at the time of cAMP addition, Ihh in the VE has already signaled the core to begin ectoderm formation.
Antagonizing Hh signaling by treatment with cAMP or forskolin: mesoderm derivatives
Embryonic ectoderm generates extraembryonic mesoderm cells and these cells, under the in¯uence of signals from the visceral endoderm, can differentiate into blood islands. Given the apparent inhibition of embryonic ectoderm differentiation in the presence of cAMP or forskolin, we examined the relative ability of control and treated embryoid bodies to form blood islands, using benzidine staining to identify erythrocytes. Under control conditions, approximately 5±30% of the embryoid bodies form blood island structures containing benzidine positive cells (Fig.  7A,D) . Few, if any, such structures were observed in treated embryoid bodies and benzidene staining was either absent or found in occasional, isolated cells (data not shown). We also investigated the effects of cAMP or forskolin treatment on the accumulation of markers of these ventral mesoderm differentiation events. Fig. 5E shows that levels of the¯t1, t4, or¯k expression are not consistently altered by either treatment at either time point, although one experiment suggests downregulation of the¯t4 gene. In contrast, both tie1 and Bh-1 expression are decreased, substantially by cAMP treatment and perhaps somewhat by forskolin treatment, at day 10. These data suggest that one outcome of Ihh signaling in the embryoid body, and perhaps in the embryo as well, is to promote vasculogenesis and hematopoiesis.
Discussion
Relatively little is known about the signals that facilitate the differentiation of visceral endoderm from a primitive endoderm precursor. In addition, the molecular nature of the signals that direct embryonic ectoderm differentiation remains poorly de®ned, although a likely source is visceral endoderm. We provide evidence to support a role for Ihh in promoting the differentiation of visceral endoderm and providing a cue to direct the differentiation of embryonic ectoderm.
We tested our hypothesis that Ihh signals are critical for both visceral endoderm and embryonic ectoderm differentiation by inhibiting Hh signaling through the use of the PKA activators cAMP and forskolin, and these results are discussed below. PKA appears to antagonize Hh by promoting processing of Gli2 and 3 polypeptides into N-terminal transcriptional repressor forms (Chen et al., 1998) . Hh signaling inhibits this processing, promoting accumulation of full length activator forms of Gil2/3 that promote gli1 expression (Dai et al., 1999) . We demonstrate here that treatment with these reagents leads to a decrease in the levels of ptc1 as well as gli1 and gli3 mRNA. Our data demonstrate that the levels of both gli1 and gli3 message are decreased in response to cAMP and forskolin treatment. This suggests that PKA may inhibit Hh signaling by acting at the transcriptional level to inhibit expression of the gli3 gene, in addition to promoting processing of the Gli3 protein.
Visceral endoderm differentiation
What is known about the molecular basis for establishing extraembryonic endoderm cell types? A primitive endoderm precursor cell can generate both visceral and parietal endoderm cells, and there are multiple examples of conditions that promote a transition from visceral to parietal endoderm. Based on gene targeting studies, Gata4, Gata6, and vHnf1 are required for visceral endoderm differentiation (Soudais et al., 1995; Barbacci et al., 1999; Cof®nier et al., 1999; Koutsourakis et al., 1999) and Hnf4 is required for its maturation from a nascent to a mature form (Duncan et al., 1997) . There is evidence that BMP signaling plays a role is establishing endoderm type. Bmp4 is expressed in the embryoid body core and the inner cell mass and embryonic ectoderm of the embryo while Bmp2 is expressed in parietal or visceral endoderm cells and perhaps in primitive endoderm (Coucouvanis and Martin, 1999) . The visceral endoderm-containing outer layer of embryoid bodies derived from the EC PSA1 cell line can switch to parietal endoderm if BMP signaling is inhibited by expression of a dominant negative BMP receptor (Bmpr-1b) transgene. In addition, embryoid bodies derived from the S2 EC cell line, which have an outer layer of parietal endoderm, can be induced to form visceral endoderm by BMP treatment (Coucouvanis and Martin, 1999) .
We provide evidence that Hh signaling also plays a role in visceral endoderm differentiation. When ES embryoid bodies differentiate in the presence of cAMP or forskolin, an outer layer of predominantly parietal endoderm forms instead of visceral endoderm. This conclusion is based upon a combination of morphological and biochemical data, including the observation that cAMP/forskolin-treated embryoid bodies downregulate AFP while upregulating tPA mRNA expression (Figs. 5 and 6) . A previous study examining the differentiation of endoderm in F9 embryoid bodies noted a transition from visceral to parietal endoderm upon addition of cAMP (Grover and Adamson, 1986) . We suggest that this transition may be attributed to suppression of Ihh signaling. These observations are consistent with our previous report that overexpression of Ihh in F9 EC cell embryoid bodies promotes visceral endoderm differentiation (Becker et al., 1997) and supports a role for Ihh signaling in visceral endoderm differentiation. An alternative interpretation is that visceral endoderm differentiation is Hh-independent, but relies upon signaling by another cAMP-responsive pathway. Future studies using additional inhibitors/promotors of Hh action, as well as genetic approaches, will help distinguish between these alternatives.
How does Ihh, expressed in visceral endoderm, promote visceral endoderm differentiation? Since there is no data to support an autocrine mechanism for Hh signaling, it is more likely that Ihh acts in an indirect manner, perhaps via the embryoid body core, since our data support a Hh response in these cells. It is possible that Hh signaling from either the primitive endoderm precursor cell or an immature visceral endoderm cell initiates downstream events in the embryoid body core. Signaling molecules are then produced in the core, perhaps activated by the Gli transcription factors. These signals then act back upon the primitive endoderm layer, promoting visceral endoderm differentiation.
Based upon our data and evidence supporting a role for BMP signaling in these events (Coucouvanis and Martin, 1999) , we propose the following general model for endoderm differentiation (Fig. 8) : primitive endoderm appears on the embryoid body or inner cell mass surface and begins to express both Ihh and BMP2. The core is already producing BMP4, and under the in¯uence of Hh signaling, it produces additional signaling molecules. These core-originating signals then promote differentiation and maturation of visceral endoderm from the primitive endoderm precursor. If primitive endoderm cells do not receive signals from the core, they become parietal endoderm cells. This mechanism can explain the differentiation of parietal endoderm in the embryo, since this cell type forms as the primitive endoderm cells leave the inner cell mass and migrate along the trophectoderm. Visceral endoderm cells can transition to parietal endoderm even after their maturation, if signals from the core are removed. This can be accomplished by inhibition of either BMP or Hh signaling (Coucouvanis and Martin, 1999) or by removing the visceral endoderm cells and placing them in monolayer culture (Casanova and Grabel, 1988) . One interesting aspect of the model as presented is that both BMP and Hh signaling appear to be required, since inhibition of either pathway can alter visceral endoderm differentiation. Since inhibition of either of these two signaling pathways has the same result, it is likely that one pathway regulates the other. Future studies will examine the interactions between Hh and BMP signaling in the embryoid body system.
A number of studies suggest a role for the signaling peptide PTHrP in parietal endoderm differentiation. PTHrP and its receptor are present at the right time and place, and addition of the peptide promotes parietal endoderm differentiation (Van de Stolpe et al., 1993; Behrendtsen et al., 1995; Verheijen et al., 1999) . Since PTHrP activates adenylate cyclase, it, like cAMP and forskolin, promotes the action of PKA, the Hh antagonist. Given the potential role of Ihh and PTHrP in extraembryonic endoderm differentiation, it is of interest that these two signals also regulate chondrogenesis .
Many EC and ES cell lines generate embryoid bodies that express a mixture of both visceral and parietal endoderm (Grabel, 1992) , and any model designed to explain the differentiation of endoderm types must take this into account. The presence of both endoderm cell types may 1/2 ptc lacZ ES embryoid bodies were grown in the presence and absence of cAMP or forskolin. In situ hybridization, Northern analysis, RT-PCR, and lacZ staining were done on samples from the same time courses. In situ hybridization and RT-PCR were performed as described in Figs. 1 and 4. (A) Day 10 embryoid bodies probed for AFP and stained for ptc/lacZ. The sections probed for AFP have been counterstained with ponceau S and picric acid, and the sections stained for lacZ have been counterstained with eosin. Note that treatment with cAMP or forskolin inhibits the expression of the visceral endoderm marker AFP, and also inhibits the expression of ptc1. Note also that the morphology of the embryoid bodies is affected by these treatments: they do not show ectoderm-lined interior cavities, and the appearance of their outer layer of endoderm is looser and not columnar (see insets for details). (B) Expression of genes in the Hh pathway. Data from two experiments are shown. Note that although expression of Ihh is not itself affected by treatment with cAMP or forskolin, gli1 and gli3 are downregulated (as is ptc1; refer to (A)). (C) Bar graph generated by scoring day 10 embryoid bodies for the following parameters: AFP expression, VE morphology, ptc/lacZ expression, embryonic ectoderm morphology, and cavitation (see Section 4). Note that based on all these parameters, the treated embryoid bodies scored lower than the untreated ones. (D) Northern analysis using the same RNA as in (B, left); 7 ml of total RNA was run in each lane. The ethidium bromide-stained lower ribosomal bands are shown as a loading control. Twin blots were probed for AFP and tPA. Note that both cAMP and forskolin cause a reduction in AFP expression and, at the same time, an increase in tPA expression, indicating a transition from visceral to parietal endoderm. (E) RT-PCR analysis of the same RNA as in (B,D) . Note that Tie-1 and Bh-1 are downregulated by cAMP and perhaps somewhat by forskolin.
indicate uneven signaling from the core. Perhaps levels below threshold result in parietal endoderm differentiation, while levels above threshold result in visceral endoderm differentiation. Fig. 6 . Effects of cAMP and forskolin when administered in a pulse. R1 1/2 ptc/lacZ embryoid bodies were grown as described. After culturing for 7 days, cAMP or forskolin were administered for the next 6 days (days 8 through 13). In situ hybridization, Northern analysis, and lacZ staining were done on samples from the same time course. (A) In situ hybridization for AFP and lacZ staining for ptc1 of day 13 embryoid bodies. The sections stained for AFP have been counterstained with ponceau S and picric acid, and the sections stained for lacZ have been counterstained with acid fuchsin. Note that under these conditions, the effects of the treatments are less pronounced and more variable than when they are administered from the beginning of embryoid body culture. (B) Bar graph quantifying the same parameters as in Fig. 5 . (There may be stochastic variations in baseline embryoid body morphology from experiment to experiment, with, for example, 50% of controls forming ectoderm in one time course and up to 90% in another. Here, and in Fig. 5C , we are comparing treated embryoid bodies with controls in the same experiment.) Note that under these conditions, forskolin affects all parameters except cavitation, but cAMP only inhibits AFP expression and VE morphology. (C) Northern analysis; 7 mg of total RNA was run in each lane, as described in Fig. 6 . The blot in the top panel was probed for tPA, rinsed, and then reprobed for AFP. Note that AFP is downregulated by forskolin at the same time that tPA is upregulated. The blot in the bottom panel shows that mRNA levels of Ihh are not affected by the treatments.
Embryonic ectoderm and cavity formation
We also propose that Hh signaling plays a role in embryonic ectoderm differentiation. Our descriptive expression data indicate that a Hh response is elicited in the embryoid body core. This response is manifested by the upregulation of ptc1 and gli genes. A role for the Hh response in maturation of the embryonic ectoderm and cavity formation is supported by the observation that ptc1 is expressed selectively in the cell layer just beneath the visceral endoderm in those cells destined to form embryonic ectoderm, and not in all of the cells of the embryoid body core. The core subsequently differentiates into a columnar layer of epithelial cells surrounding a¯uid ®lled cavity analogous to the proamniotic cavity. The cavity forms via a process of spatially selective apoptosis.
A role for Ihh signaling in ectoderm differentiation is further supported by our observation that inhibition of Hh signaling blocks the formation of an embryonic ectoderm layer surrounding a cavity. Embryoid bodies remain in an immature state with no cavities. There is evidence that BMP signaling also plays a key role in embryoid body differentiation. The EC cell line PSA1 forms embryoid bodies that undergo cavitation by localized programmed cell death (Coucouvanis and Martin, 1995) , but this process is inhibited by expression of the dominant negative Bmpr-1b transgene (Coucouvanis and Martin, 1999) . The EC cell line S2 forms embryoid bodies surrounded by parietal endoderm that are unable to generate cavities or form an embryonic ectoderm layer (Coucouvanis and Martin, 1999) . We observe the same outcome for ES embryoid bodies treated with cAMP or forskolin. When S2 embryoid bodies are treated with BMPs, parietal endoderm transitions to visceral endoderm and cavities begin to form. These data suggest that a visceral endoderm layer is required for embryoid body core maturation.
The observation that inhibition of either Hh or BMP signaling results in both a transition of endoderm type and inhibition of core differentiation makes it dif®cult to determine if these signals play a direct or indirect role in ectoderm differentiation. The absence of cavitation and ectoderm differentiation observed when either Hh or BMP signaling is inhibited may be attributed to the transition of endoderm cell type. In this scenario, Ihh/BMP signaling would promote ectoderm differentiation only indirectly by promoting visceral endoderm differentiation. The visceral endoderm would then be the source of additional signals, distinct from Ihh or BMP2, essential for core maturation. Alternatively, Ihh/BMP2 may be the signals produced by the visceral endoderm that promote embryonic ectoderm differentiation. Future studies using reagents and protocols that can more speci®cally target these later events without generating an endoderm transition must be performed to distinguish between these two alternatives.
Mesoderm derivatives
Ihh continues to be expressed in the visceral endoderm of embryoid bodies and embryos when mesoderm forms and differentiates. The observation that ptc expression is elevated in the extraembryonic mesoderm-derived mesothelial layer of the visceral yolk sac, adjacent to the hemangioblast precursors that differentiate into blood and endothelial cells, led us to hypothesize that Ihh signaling also plays a role in yolk sac differentiation. Our observation that cAMP or forskolin treatment inhibits the accumulation of Bh-1, embryonic globin, and tie1, which encodes an orphan receptor related to Tie2 that is required for blood vessel integrity, supports this hypothesis. However, the changes we observe in blood and blood vessel formation may be due to the visceral to parietal endoderm transition observed since it has been shown that the visceral endoderm is the source of signals required for initiation of hematopoiesis (Belaoussoff et al., 1998) .
Phenotype of the Ihh-de®cient mice
We propose that Ihh functions early in visceral endoderm differentiation and later in the differentiation of embryonic ectoderm derivatives. The phenotype of Ihh-de®cient mice supports our hypothesis (St-Jacques et al., 1999) . In addition to skeletal abnormalities, 50% of the null embryos die between days 10.5 and 12.5, with circulatory problems as the likely cause of death. The visceral yolk sac defect may be attributed to the absence of Ihh in the visceral endoderm. This preliminary observation is consistent with our hypothesis for Ihh function in yolk sac differentiation. The lack of penetrance of the mutation (only 50% display the yolk sac phenotype) may be attributed to upregulation of alternate Hh genes or the presence of maternal Hh. The observation that visceral endoderm forms normally in the mutant embryos suggests that either Ihh does not play a role in this event, or that its function is redundant or replaced by a maternal source. Alternatively the visceral endoderm may appear normal, but be immature in these embryos. The use of more speci®c inhibitors of Hh signaling, such as functionblocking antibodies and the cholesterol-like alkaloid cyclopamine, is currently underway, and combined with more detailed analysis of the circulatory defect in the Ihh-defective mice, these studies will help de®ne the role of Ihh in early development.
Conclusions
We present evidence for a Hh response in the embryoid body core and in the mesoderm layer of the visceral yolk sac. Treatment of differentiating ES embryoid bodies with cAMP or forskolin results in a marked downregulation of this Hh response. These treatments also alter embryoid body differentiation, promoting a transition from visceral to parietal endoderm and inhibiting the formation of an embryonic ectoderm layer surrounding a cavity. The expression of mesoderm markers is also altered when Hh signaling is inhibited.
Experimental procedures
ES cell culture
ES cells were maintained on STO or neo-resistant STO ®broblast feeder layers in DMEM (GIBCO) and 15% fetal calf serum (Hyclone) in the presence of recombinant LIF. Embryoid bodies were formed by removing the stem cells from the feeder layer and culturing them in suspension (Doetschman et al., 1985) . D3 ES cells were a gift from Brigid Hogan. R1 ptc 1/2 lacZ ES cells were a gift from Mathew Scott. For experiments involving cAMP and forskolin, dibutyryl cyclic AMP (Sigma) was added at 0.5 mM, and forskolin (Sigma) was added at 2.5 mM. Treatments were added and culture medium was changed each day.
In situ hybridization
Whole mount in situ hybridization on both embryos and Fig. 8 . Model outlining the role of Hh and BMP signaling in visceral endoderm and embryonic ectoderm differentiation. Early stage embryoid bodies accumulate BMP4. The outer layer differentiates into primitive endoderm, and these cells begin to secrete BMP2 and Ihh, which in¯uence the differentiation of the embryoid body core. The core upregulates ptc1 and gli expression, and this Hh response results in the production of signals from the core which, in combination with BMP4 and BMP-induced signals, act back upon the primitive endoderm to promote its differentiation into visceral endoderm. Once visceral endoderm forms, it signals the core to differentiate a single layer of embryonic ectoderm surrounding a cavity formed by programmed cell death. These signals from the visceral endoderm may include BMP2 and Ihh, or be distinct visceral endoderm speci®c products.
embryoid bodies was performed as described in Jowett (1997) . Day 8 mouse embryos were a gift from the lab of J. Madri, and embryoid bodies were grown as described above. After completion of the staining, the samples were post-®xed in 3.7% formaldehyde, dehydrated through methanol, then isopropanol, and then embedded in paraf®n for sectioning. Some sections were counterstained with either eosin, ponceau S and picric acid, or acid fuchsin (Humason, 1972) . Sectioned embryos and embryoid bodies were photographed with a digital camera (SPOT).
Immunocytochemistry
ES D3 embryoid bodies were ®xed, dehydrated, and embedded in paraf®n. Immunocytochemistry using standard protocols was performed on paraf®n sections using the monoclonal antibody 5E1 (University of Iowa hybridoma bank), which was raised against Shh but cross-reacts with Ihh, and ptc1 (Santa Cruz Biotechnologies). Brie¯y, slides were dewaxed in xylenes, rehydrated into PBS, permeablized in 0.2% Triton X-100 in PBS, blocked in 1% BSA/ PBS, incubated in primary antibody diluted in BSA/PBS, washed in PBS, incubated in secondary antibody diluted in BSA/PBS, washed in PBS, and ®nally the signal was visualized with DAB (tablets from Sigma). 5E1 was used at a 1/ 10 dilution and detected using a 1/500 dilution of an HRPconjugated goat anti-mouse secondary (Transduction Labs). Ptc1 was used at a 1/100 dilution and detected using a 1/200 dilution of an HRP-conjugated horse anti-goat secondary antibody (Vector).
Probes
Digoxigenin-labeled RNA probes used for both in situ hybridization and Northern analysis were made using standard in vitro labeling protocols. Probes used were Ihh (1.8 kb labeled transcript) (gift of A. McMahon), Ptc1 (841 bp transcript) (gift of M. Scott), AFP (960 bp transcript) (gift of S. Tilghman), tPA (2.5 kb transcript) (gift of S. Strickland), gli1 (1.7 kb), gli2 (1 kb), and gli3 (800 bp) (gift of A. Joyner).
RT-PCR
Total RNA was extracted from embryoid bodies at various stages of development using Ultraspec-RNA (Biotecx). RNA was treated with ampli®cation grade DNaseI (GIBCO BRL) and then reverse-transcribed with MMLV-RT (GIBCO BRL) according to the manufacturer's protocols. cDNA was ampli®ed with various oligonucleotide primers using Taq DNA polymerase (Sigma). PCR conditions were optimized for each set of primers. Primers used are listed in Table 1 . Some were designed in our laboratory; the others are referenced.
LacZ staining
An R1 ptc 1/2 ES cell line that expresses LacZ under the control of the ptc1 promoter was cultured as described above, and embryoid bodies were grown as described above. Embryoid bodies were harvested, ®xed, and stained for b-galactosidase activity as previously described (Mendelsohn et al., 1991) . After staining, the material was post-®xed, dehydrated and embedded in paraf®n for sectioning.
Benzidine staining for hemoglobin
Embryoid bodies were rinsed in PBS, then incubated for 10 min in PBS containing 20% v/v of 2 mg/ml benzidine (Sigma) in 0.5 M acetic acid and 3 ml/ml 30% H 2 O 2 (Downs Keller et al., 1993 and Harmann, 1997). Hemoglobin-containing cells were stained dark blue. Embryoid bodies were then ®xed, dehydrated in methanol, embedded in paraf®n and sectioned. The stain after dehydration and embedding turns brownish orange.
Northern analysis
Total RNA was extracted as for RT-PCR and run through formaldehyde-containing gels as described in Maniatis et al. (1982) , and blotted onto Magnagraph membranes (Micron Separations, Inc.). Probes were the same as those used for in situ hybridization. Northern hybridization was done at high stringency, and the signal was visualized using the CSPD chemiluminescent detection system (BMB). Exposure times were from 10 min to 1 h, and multiple exposures were taken of each blot.
Scoring of embryoid body morphology
Embryoid bodies treated and untreated with cAMP or forskolin were scored for the following parameters: AFP expression (embryoid bodies showing expression in any cells were scored positive); VE morphology (embryoid bodies showing any tightly associated columnar endoderm were scored positive); ptc/lacZ expression (embryoid bodies showing any lacZ staining were scored positive); embryonic ectoderm morphology (embryoid bodies showing any columnar ectodermal morphology in the cell layer beneath the endoderm were scored positive); and cavitation (embryoid bodies showing any cavities inside the embryonic ectoderm layer were scored positive). Seventy to 100 embryoid bodies were counted on each slide, and the percentages were used to generate Figs. 5C and 6B. Note that these scoring criteria do not take into account differences in intensity of AFP or lacZ signal.
